Human cytomegalovirus UL7, miR-US5-1 and miR-UL112-3p inactivation of FOXO3a protects CD34+ hematopoietic progenitor cells from apoptosis

• Published in: bioRxiv
• Main Authors: Hancock, Meaghan H, Crawford, Lindsey B, Perez, Wilma, Struthers, Hillary M, Mitchell, Jennifer, Caposio, Patrizia
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 29.09.2020
• Subjects: Apoptosis; CD34 antigen; Cell death; Cytomegalovirus; FOXO3 protein; Genomes; Hematopoietic stem cells; Immune system; Infections; Latency; Latent infection; Monocytes; Progenitor cells; Proteins; Transcription activation; Transcription factors; Transplantation; Viruses
• DOI: 10.1101/2020.09.28.317859

Abstract Human cytomegalovirus (HCMV) infection of myeloid-lineage cells, such as CD34+ hematopoietic progenitor cells (HPCs) or monocytes results in the upregulation of anti-apoptotic cellular proteins that protect the newly infected cells from programmed cell death. The mechanisms used by HCMV to regulate pro-apoptotic cellular proteins upon infection of CD34+ HPCs has not been fully explored. Here we show that HCMV utilizes pUL7, a secreted protein that signals through the FLT3 receptor, and miR-US5-1 and miR-UL112-3p to reduce the abundance and activity of the pro-apoptotic transcription factor FOXO3a at early times after infection of CD34+ HPCs. Regulation of FOXO3a by pUL7, miR-US5-1 and miR-UL112 results in reduced expression of the pro-apoptotic BCL2L11 transcript and protection of CD34+ HPCs from virus-induced apoptosis. These data highlight the importance of both viral proteins and miRNAs in protecting CD34+ HPCs from apoptosis at early times post-infection, allowing for the establishment of latency and maintenance of viral genome-containing cells. Importance Human cytomegalovirus (HCMV) causes serious disease in immunocompromised individuals and is a significant problem during transplantation. The virus can establish a latent infection in CD34+ hematopoietic progenitor cells (HPCs) and periodically reactivate to cause disease in the absence of an intact immune system. What viral gene products are required for successful establishment of latency are still not fully understood. Here we show that both a viral protein and viral miRNAs are required to prevent apoptosis after infection of CD34+ HPCs. HCMV pUL7 and miRNAs miR-US5-1 and miR-UL112-3p act to limit the expression and activation of the transcription factor FOXO3a which in turn reduces expression of pro-apoptotic gene BCL2L11 and prevents virus-induced apoptosis in CD34+ HPCs.